A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow

´ëÇÑÇ÷¾×ÇÐȸÁö 2014³â 49±Ç 2È£ p.127 ~ p.129

º¯¿µÀç(Byun Young-Jae) - Hanyang University College of Medicine Department of Internal Medicine
¹Úº´¹è(Park Byeong-Bae) - Hanyang University College of Medicine Department of Internal Medicine
ÀÌÀº¼º(Lee Eun-Sung) - Hanyang University College of Medicine Department of Internal Medicine
ÃÖ°æ¼ö(Choi Kyung-Soo) - Hanyang University College of Medicine Department of Internal Medicine
À̴뼺(Lee Dae-Sung) - Hanyang University College of Medicine Department of Internal Medicine

Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by over-production of myeloid white blood cells. Philadelphia chromosome is an essential finding for CML diagnosis. Generally, a clinical diagnosis of essential thrombocythemia (ET) can be established from isolated marked thrombocytosis in peripheral blood. However, Philadelphia chromosome-positivity or bcr/abl rearrangement with isolated thrombocy-tosis should be diagnosed as CML, not ET, according to World Health Organization diag-nostic criteria. Therefore, CML should not be excluded before confirming the presence of the Philadelphia chromosome or bcr/abl rearrangement in cases of isolated thrombocy-tosis in peripheral blood. We report a case of CML with clinical features of ET in a patient successfully treated with imatinib.

Ű¿öµå

Chronic myeloid leukemia, Philadelphia chromosome, Essential thrombocythemia
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå